Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxideSimon Couillard, Ian Pavord, Annette Laugerud et al.|Thorax|2021Cited by 169
Blood Eosinophil Depletion with Mepolizumab, Benralizumab, and Prednisolone in Eosinophilic AsthmaAngela Moran, Lauri Lehtimäki, Sanjay Ramakrishnan et al.|American Journal of Respiratory and Critical Care Medicine|2020Cited by 76
Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a patient-level meta-analysis of control groups of 22 randomised trialsFleur L. Meulmeester, Simon Couillard, C.A. Celis-Preciado et al.|The Lancet Respiratory Medicine|2025Cited by 69
Prevention of Cardiovascular and Other Systemic Adverse Outcomes in Patients with Asthma Treated with BiologicsMohsen Sadatsafavi, Κonstantinos Κostikas, Trung N. Tran et al.|American Journal of Respiratory and Critical Care Medicine|2025Cited by 17
Antibiotics for asthma attacks: masking uncertaintySanjay Ramakrishnan, Simon Couillard|European Respiratory Journal|2021Cited by 10